ArticleBMJ open2018

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).

Marloes Stam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.